These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Pyridostigmine for reversal of severe sequelae from botulinum toxin injection. Young DL; Halstead LA J Voice; 2014 Nov; 28(6):830-4. PubMed ID: 25008379 [TBL] [Abstract][Full Text] [Related]
5. Distant effects of locally injected botulinum toxin: incidence and course. Lange DJ; Brin MF; Fahn S; Lovelace RE Adv Neurol; 1988; 50():609-13. PubMed ID: 2840809 [No Abstract] [Full Text] [Related]
6. BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study). Truong DD; Cullis PA; O'Brien CF; Koller M; Villegas TP; Wallace JD Mov Disord; 1997 Sep; 12(5):772-5. PubMed ID: 9380065 [TBL] [Abstract][Full Text] [Related]
7. The effects of botulinum toxin on ocular tissue. Smith H Nurs Times; 1995 Jan 25-31; 91(4):41-3. PubMed ID: 7862573 [TBL] [Abstract][Full Text] [Related]
8. Development of botulinum toxin therapy. Hermanowicz N; Truong DD West J Med; 1995 Nov; 163(5):472-3. PubMed ID: 8533413 [No Abstract] [Full Text] [Related]
9. Adductor laryngeal breathing dystonia in a patient with lubag (X-linked dystonia-Parkinsonism syndrome). Lew MF; Shindo M; Moskowitz CB; Wilhelmsen KC; Fahn S; Waters CH Mov Disord; 1994 May; 9(3):318-20. PubMed ID: 8041372 [TBL] [Abstract][Full Text] [Related]
11. A case of painless arms/moving fingers responsive to botulinum toxin a injections. Singer C; Papapetropoulos S Parkinsonism Relat Disord; 2007 Feb; 13(1):55-6. PubMed ID: 16723267 [TBL] [Abstract][Full Text] [Related]
13. Dosage changes in patients with long-term botulinum toxin use for laryngeal dystonia. Birkent H; Maronian N; Waugh P; Merati AL; Perkel D; Hillel AD Otolaryngol Head Neck Surg; 2009 Jan; 140(1):43-7. PubMed ID: 19130960 [TBL] [Abstract][Full Text] [Related]
14. [Clinical application of botulinum toxin]. Grandas F Neurologia; 1995; 10(6):224-33. PubMed ID: 7546812 [No Abstract] [Full Text] [Related]
15. Dystonia and headaches: clinical features and response to botulinum toxin therapy. Galvez-Jimenez N; Lampuri C; PatiƱo-Picirrillo R; Hargreave MJ; Hanson MR Adv Neurol; 2004; 94():321-8. PubMed ID: 14509690 [No Abstract] [Full Text] [Related]
16. Flupenthixol-induced tardive dystonia presenting as severe dysphagia. Agarwal PA; Ichaporia NR Neurol India; 2010; 58(5):784-5. PubMed ID: 21045513 [No Abstract] [Full Text] [Related]
17. Botulinum toxin for people with dystonia treated by an outreach nurse practitioner: a comparative study between a home and a clinic treatment service. Whitaker J; Butler A; Semlyen JK; Barnes MP Arch Phys Med Rehabil; 2001 Apr; 82(4):480-4. PubMed ID: 11295008 [TBL] [Abstract][Full Text] [Related]